Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
European Centre for Disease Prevention and Control
2018
|
| _version_ | 1826270068398358528 |
|---|---|
| author | Rondy, M Kissling, E Emborg, H Gherasim, A Pebody, R Trebbien, R Pozo, F Larrauri, A McMenamin, J Valenciano, M I-Move/I-Move+ Group |
| author2 | De Lusignan, S |
| author_facet | De Lusignan, S Rondy, M Kissling, E Emborg, H Gherasim, A Pebody, R Trebbien, R Pozo, F Larrauri, A McMenamin, J Valenciano, M I-Move/I-Move+ Group |
| author_sort | Rondy, M |
| collection | OXFORD |
| description | Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates. |
| first_indexed | 2024-03-06T21:35:04Z |
| format | Journal article |
| id | oxford-uuid:45f62088-4374-4cc4-b7df-43089305f1e1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:35:04Z |
| publishDate | 2018 |
| publisher | European Centre for Disease Prevention and Control |
| record_format | dspace |
| spelling | oxford-uuid:45f62088-4374-4cc4-b7df-43089305f1e12022-03-26T15:10:56ZInterim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:45f62088-4374-4cc4-b7df-43089305f1e1EnglishSymplectic Elements at OxfordEuropean Centre for Disease Prevention and Control2018Rondy, MKissling, EEmborg, HGherasim, APebody, RTrebbien, RPozo, FLarrauri, AMcMenamin, JValenciano, MI-Move/I-Move+ GroupDe Lusignan, SBetween September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates. |
| spellingShingle | Rondy, M Kissling, E Emborg, H Gherasim, A Pebody, R Trebbien, R Pozo, F Larrauri, A McMenamin, J Valenciano, M I-Move/I-Move+ Group Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_full | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_fullStr | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_full_unstemmed | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_short | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_sort | interim 2017 18 influenza seasonal vaccine effectiveness combined results from five european studies |
| work_keys_str_mv | AT rondym interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT kisslinge interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT emborgh interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT gherasima interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT pebodyr interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT trebbienr interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT pozof interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT larrauria interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT mcmenaminj interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT valencianom interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT imoveimovegroup interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies |